Are Analysts Bearish CME Group Inc. (NASDAQ:CME) After Last Week?

January 19, 2018 - By Michael Collier

 Are Analysts Bearish CME Group Inc. (NASDAQ:CME) After Last Week?
Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.12, from 1.13 in 2017Q2. It dived, as 53 investors sold CME Group Inc. shares while 219 reduced holdings. 56 funds opened positions while 220 raised stakes. 265.89 million shares or 1.13% less from 268.92 million shares in 2017Q2 were reported.
Sumitomo Life Insurance Com has invested 0.4% in CME Group Inc. (NASDAQ:CME). Dimensional Fund Advsr L P accumulated 1.07 million shares or 0.06% of the stock. Union Bankshares Corporation reported 0.08% in CME Group Inc. (NASDAQ:CME). Zwj Counsel holds 2,540 shares or 0.03% of its portfolio. The New York-based Natl Asset Management Inc has invested 0.13% in CME Group Inc. (NASDAQ:CME). Caisse De Depot Et Placement Du Quebec holds 0% of its portfolio in CME Group Inc. (NASDAQ:CME) for 7,791 shares. Moreover, Ontario Teachers Pension Plan Board has 0.13% invested in CME Group Inc. (NASDAQ:CME) for 72,402 shares. Hbk Sorce Advisory Ltd Liability Corp reported 0.06% in CME Group Inc. (NASDAQ:CME). Laurion Capital Mngmt Lp holds 0.02% of its portfolio in CME Group Inc. (NASDAQ:CME) for 33,775 shares. Old Mutual Customised Solutions (Proprietary) Limited reported 12,090 shares. Everence Capital Management Inc accumulated 7,065 shares. Integral Derivatives owns 2,648 shares or 0.01% of their US portfolio. Moreover, Bbva Compass Bank has 0.02% invested in CME Group Inc. (NASDAQ:CME). Advisor Ptnrs Ltd Liability Com holds 6,213 shares. 5,214 were reported by Archford Strategies Llc.

Since August 2, 2017, it had 0 insider buys, and 12 insider sales for $7.73 million activity. 11,915 shares were sold by Holzrichter Julie, worth $1.50 million on Monday, August 7. $37,434 worth of CME Group Inc. (NASDAQ:CME) was sold by Pankau Ronald A. on Thursday, August 3. The insider Tobin Jack J sold 2,325 shares worth $354,051. Shares for $107,653 were sold by GLICKMAN DANIEL R. DUFFY TERRENCE A had sold 21,815 shares worth $2.70M. Pietrowicz John W. also sold $1.14M worth of CME Group Inc. (NASDAQ:CME) shares.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

Among 15 analysts covering CME Group (NASDAQ:CME), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. CME Group had 51 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given on Friday, January 8 by Deutsche Bank. The stock of CME Group Inc. (NASDAQ:CME) earned “Overweight” rating by JP Morgan on Wednesday, January 13. The firm has “Buy” rating given on Friday, July 29 by UBS. The stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given on Wednesday, August 31 by Jefferies. The stock of CME Group Inc. (NASDAQ:CME) earned “Overweight” rating by Barclays Capital on Tuesday, October 10. The company was maintained on Tuesday, August 1 by RBC Capital Markets. Citigroup maintained CME Group Inc. (NASDAQ:CME) rating on Thursday, October 19. Citigroup has “Buy” rating and $155 target. The company was maintained on Wednesday, October 4 by Wells Fargo. The company was maintained on Monday, June 12 by RBC Capital Markets. Below is a list of CME Group Inc. (NASDAQ:CME) latest ratings and price target changes.

16/01/2018 Broker: Jefferies Rating: Buy New Target: $175.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $160.0 Maintain
19/10/2017 Broker: Citigroup Rating: Buy Old Target: $138 New Target: $155 Maintain
16/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $147.0 Maintain
10/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $138.0 Maintain
10/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $139 New Target: $149 Maintain
04/10/2017 Broker: Wells Fargo Rating: Market Perform Old Target: $130 New Target: $145 Maintain
27/09/2017 Broker: Jefferies Rating: Buy New Target: $134.0 Maintain
18/09/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $133.0 Maintain
11/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $135.0 Maintain

The stock increased 1.17% or $1.78 during the last trading session, reaching $153.99. About 584,609 shares traded. CME Group Inc. (NASDAQ:CME) has risen 25.35% since January 19, 2017 and is uptrending. It has outperformed by 8.65% the S&P500.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The company has market cap of $52.40 billion. The firm offers a range of products across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. It has a 34.92 P/E ratio. The Company’s products include exchange-traded; and privately negotiated futures and options contracts and swaps.

More notable recent CME Group Inc. (NASDAQ:CME) news were published by: Reuters.com which released: “CME Group expands private trades in grain markets, raising worries” on January 05, 2018, also Prnewswire.com with their article: “What’s Happening With These Investment Brokerage Stocks? — TD Ameritrade, BGC …” published on January 19, 2018, Nasdaq.com published: “Bull of the Day: CME Group (CME)” on January 10, 2018. More interesting news about CME Group Inc. (NASDAQ:CME) were released by: Nasdaq.com and their article: “CME Group (CME) Posts Record Volumes for 2017, Shares Up” published on January 04, 2018 as well as Prnewswire.com‘s news article titled: “CME Group Inc. Announces Fourth-Quarter and Full-Year 2017 Earnings Release …” with publication date: December 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.